Guru Ownership Trend
Guru Analysis for Cullinan Therapeutics, Inc. (CGEM)
Cullinan Therapeutics, Inc. (CGEM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $27.74 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $8.99 M net outflow during the quarter.
Recent activity highlights Ken Fisher who opened a new position. Conversely, Steven Cohen reduced exposure by 91.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Cullinan Therapeutics, Inc. (CGEM)
Major holders include Cliff Asness ($10.59 M), Renaissance Technologies (RenTech) ($5.95 M), Louis Moore Bacon ($3.46 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 1.23 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $8.99 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited CGEM. The total reported sell value was $15.24 M.
Yes, 1 managers opened new positions in CGEM, and 3 increased their existing holdings. The total reported buy value was $6.25 M.